A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY)

חו"ל (דורש נסיעה)מגייס משתתפיםPHASE2

מצבים רפואיים

Pulmonary Arterial Hypertension (PAH) · Pulmonary Hypertension, Interstitial Lung Disease

סיכום בשפה פשוטהבעזרת בינה מלאכותית

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים
  • Arizona Pulmonary Specialists, Phoenix, Arizona, United States

    Contact: Study coordinator (Arizona Pulmonary Specialist) · info@allrockbio.com · 857-239-1966
  • University of California Davis Health, Rancho Cordova, California, United States

    Contact: Study coordinator (University of California Davis Health) · info@allrockbio.com · 857-239-1966
  • University of Colorado, Aurora, Colorado, United States

    Contact: Study coordinator (University of Colorado) · info@allrockbio.com · 857-239-1966
  • George Washington University Medical, Washington D.C., District of Columbia, United States

    Contact: Study coordinator (George Washington University Medical) · info@allrockbio.com · 857-239-1966
  • Mayo Clinic of Florida, Jacksonville, Florida, United States

    Contact: Study coordinator (Mayo Clinic of Florida) · info@allrockbio.com · 857-239-1966
  • The University of Kansas Medical Center Research Institute, Kansas City, Kansas, United States

    Contact: Study coordinator (The University of Kansas Medical Center Research Institute) · info@allrockbio.com · 857-239-1966
  • University of Michigan, Ann Arbor, Michigan, United States

    Contact: Study coordinator (University of Michigan) · info@allrockbio.com · 857-239-1966
  • Ohio State University, Columbus, Ohio, United States

    Contact: Study coordinator (Ohio State University) · info@allrockbio.com · 857-239-1966
  • Bend Memorial Clinic, Bend, Oregon, United States

    Contact: Study coordinator (Bend Memorial Clinic) · info@allrockbio.com · 857-239-1966
  • Temple University, Philadelphia, Pennsylvania, United States

    Contact: Study coordinator (Temple University) · info@allrockbio.com · 857-239-1966
  • Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia

    Contact: Study coordinator (Royal Prince Alfred Hospital) · info@allrockbio.com · 857-239-1966
  • Pulmonary Hypertension Research Queensland, Auchenflower, Queensland, Australia

    Contact: Study coordinator (Pulmonary Hypertension Research Queensland) · info@allrockbio.com · 857-239-1966
  • Peter Lougheed Centre, Calgary, Alberta, Canada

    Contact: Study coordinator (Peter Lougheed Centre) · info@allrockbio.com · 857-239-1966
  • London Health Ontario, London, Ontario, Canada

    Contact: Study coordinator (London Health Ontario) · info@allrockbio.com · 857-239-1966
  • CHU de BICETRE SERVICE PNEUMOLOGIE, Le Kremlin-Bicêtre, Val-de-Marne, France

    Contact: Study coordinator (CHU de BICETRE SERVICE PNEUMOLOGIE) · info@allrockbio.com · +1-857-239-1966
  • Medizinische Hochschule Hannover, Hanover, Lower Saxony, Germany

    Contact: Study coordinator (Medizinische Hochschule Hannover) · info@allrockbio.com · 857-239-1966
  • Fondazione IRCCS Policlinico San Matteo, Pavia, Lombardy, Italy

    Contact: Study coordinator (Fondazione IRCCS Policlinico San Matteo) · info@allrockbio.com · 857-239-1966
  • Pauls Stradins Clinical University Hospital, Riga, Latvia

    Contact: Study coordinator (Pauls Stradins Clinical University Hospital) · info@allrockbio.com · 857-239-1966
  • Hospital Universitario 12 de Octubre, Madrid, Madrid, Spain

    Contact: Study coordinator (HOSPITAL UNIVERSITARIO 12 DE OCTUBRE) · info@allrockbio.com · +1-857-239-1966